KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Account Payables (2017 - 2022)

Guardant Health's Change in Account Payables history spans 6 years, with the latest figure at $6.7 million for Q3 2022.

  • For Q3 2022, Change in Account Payables rose 3951.45% year-over-year to $6.7 million; the TTM value through Sep 2022 reached $19.5 million, up 1201.42%, while the annual FY2021 figure was $8.6 million, 209.91% up from the prior year.
  • Change in Account Payables for Q3 2022 was $6.7 million at Guardant Health, down from $11.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $12.0 million in Q1 2021 and bottomed at -$12.0 million in Q2 2020.
  • The 5-year median for Change in Account Payables is $1.7 million (2021), against an average of $1.5 million.
  • The largest annual shift saw Change in Account Payables plummeted 322.35% in 2020 before it soared 3951.45% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $1.7 million in 2018, then skyrocketed by 130.57% to $3.9 million in 2019, then tumbled by 322.35% to -$8.7 million in 2020, then surged by 119.52% to $1.7 million in 2021, then surged by 292.17% to $6.7 million in 2022.
  • Per Business Quant, the three most recent readings for GH's Change in Account Payables are $6.7 million (Q3 2022), $11.8 million (Q2 2022), and -$753000.0 (Q1 2022).